A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions

Overview of attention for article published in Pharmacogenomics and Personalized Medicine, March 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 36,226 followers.

Here my recent collaborative work on pharmacogenetics of severe ADRs https://t.co/RtHTlauHIh https://t.co/wZILYh5vDR

25 Mar 2020

Reply Repost Favourite

More and more off-target adverse drug reactions are being explained by pharmacogenomic predisposition. Enter..personalised medicine.

02 Mar 2020

Reply Repost Favourite

A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis | PGPM - Dove Medical Press https://t.co/uT46fZF277

02 Mar 2020

Reply Repost Favourite

A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions https://t.co/xF3yB2tDUJ

01 Mar 2020

Reply Repost Favourite

Dove Medical Press

Article Metrics

A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions

About this Attention Score

Mentioned by

Citations

Readers on